|
In memory of Dr. ATW Simeons, creator of the method
Introduction
Obesity is a major cause of concern worldwide and particularly in the
United States, where it currently represents a significant health threat
to the population. Reportedly, obesity is a major contributing factor in
the death of approximately 300,000 Americans a year. The population of
obese men and women increased from 12 percent to 17.9 percent between 1991
and 1998, according to a survey conducted by the CDC (Center for Disease
Control). Other research points out that more than 50% of Americans are
overweight and 22% of them are obese. (Reference:
Studies: Obesity kills but you can fight back )
Nowadays, it is rare to pick up a newspaper or listen to a news broadcast
in the US without hearing about the disproportionate surge in obesity that
has taken place in the last few years. The CDC calls it a serious
epidemic. In a letter to the editor published in the October 4 issue of
the Journal of the American Medical Association, Dr. Jeffrey Koplan, M.D
describes obesity as a continuing epidemic of critical public health
concern and advises that we need to respond to it as vigorously as we do
to an infectious disease epidemic
(Reference: Obesity in America – Mayo Clinic Health Oasis.)
What is even more alarming is that this epidemic is affecting our
children. A growing number of teenagers are now developing diseases such
as type 2 diabetes that put them at risk for complications such as kidney
and heart disease, blindness and nerve degeneration in their arms and
legs.
(Reference: Unhealthy lifestyle exacts heavy toll from children.)
Several treatments for obesity have been prescribed over the years
with varying rates of success and health risk factors. Higher risk
surgical treatments have been suggested for some patients; for example
those with a body mass index (BMI) of 40 or greater. Other obesity
management programs combine behavior modification with adjunctive
pharmacotherapy.
The hCG (Human Choriogonadotropin) method is among the successful
approaches to obesity management. However, few obesity treatments have
been so neglected and misunderstood regarding their potential therapeutic
effect. It is our firm belief that this approach to obesity, first
reviewed in The Lancet
almost fifty years ago, merits another unbiased, scientific look.
We set forth that much of the negative publicity surrounding the procedure
is due to the lack of proper validation by the appropriate governmental
agencies, such that it has been marginally performed often by untrained
personnel, under uncontrolled conditions. Thus, the protocol has been
modified or misinterpreted, leading to unsuccessful results.
Moreover, we are convinced that, notwithstanding efforts to discredit it,
the hCG method continues to attract the attention of healthcare
professionals and patients alike. We base this on the large number of
requests for information and favorable comments received through this web
site from patients and healthcare professionals around the world.
In response to the increasing requests for information about the hCG
program, we have created the International Foundation for hCG (human
Choriogonadotropin) and Obesity Research (ISAUC). The mission of the
Foundation is to restore the hCG method to its original protocol by making
training available to interested physicians and providing patients with
the necessary data on which to base an informed decision.
Invitation
Accordingly, we invite the healthcare professionals and patients who have
expressed an interest in the hCG treatment through this web site, to
attend an International Workshop on hCG and obesity to take place from
September 24 to 26, 1992-2007, in Buenos Aires, Argentina.
The purpose of this event is to share information and
ideas on the hCG use for obesity treatment, generate consensus documents
and outline the studies that would need to be performed and presented to
interested governmental agencies to establish the credibility of this
method for the treatment of obesity .In addition, participants will have a
unique opportunity to meet others interested in this topic.
If interested in attending, please complete and submit the
registration form here...
Sincerely,
Dr. Daniel Belluscio
Director- The International Society for Alternative Uses of human Choriogonadotropin (ISAUC)
Comments
|
